Inhibiting CBX4 efficiently protects hepatocellular carcinoma cells against sorafenib resistance - Zhao, W.; Ma, B.; Tian, Z.; Han, H.; Tang, J.; Dong, B. (Br J Cancer, 2021)

Classification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations - Fujita, M.; Yamaguchi, R.; Hasegawa, T.; Shimada, S.; Arihiro, K.; Hayashi, S. (EBioMedicine, 2020)

Cancer statistics, 2021 - Siegel, R. L.; Miller, K. D.; Fuchs, H. E.; Jemal, A. (CA Cancer J Clin, 2021)

Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing - Zhang, H.; Dong, P.; Guo, S.; Tao, C.; Chen, W.; Zhao, W. (BMC Med, 2020)

Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes - Gu, X.; Guan, J.; Xu, J.; Zheng, Q.; Chen, C.; Yang, Q. (J Transl Med, 2021)

TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3 - Liu, S.; Qiu, J.; He, G.; He, W.; Liu, C.; Cai, D. (Cancer Cell Int, 2021)

Angiogenesis-related non-coding RNAs and gastrointestinal cancer - Razavi, Z. S.; Asgarpour, K.; Mahjoubin-Tehran, M.; Rasouli, S.; Khan, H.; Shahrzad, M. K. (Mol Ther Oncol, 2021)

Shafabakhsh R, Arianfar F, Vosough M, Mirzaei HR, Mahjoubin-Tehran M, Khanbabaei H, et al. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance. Cancer Gene Ther. 2021.

Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis - Martel, C.; Georges, D.; Bray, F.; Ferlay, J.; Clifford, G. M. (Lancet Glob Health, 2020)

Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma - Tian, M. X.; Liu, W. R.; Wang, H.; Zhou, Y. F.; Jin, L.; Jiang, X. F. (BMC Med, 2019)

Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinoma - Zhou, K. Q.; Sun, Y. F.; Cheng, J. W.; Du, M.; Ji, Y.; Wang, P. X. (EBioMedicine, 2020)

Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis - Zou, Y.; Li, H.; Graham, E. T.; Deik, A. A.; Eaton, J. K.; Wang, W. (Nat Chem Biol, 2020)

Identification of LPCAT1 expression as a potential prognostic biomarker guiding treatment choice in acute myeloid leukemia - Wang, K.; Wu, Z.; Si, Y.; Tang, W.; Xu, X.; Cheng, Y. (Oncol Lett, 2021)

Macrophage lysophosphatidylcholine acyltransferase 3 deficiency-mediated inflammation is not sufficient to induce atherosclerosis in a mouse model - Jiang, H.; Li, Z.; Huan, C.; Jiang, X. C. (Front Cardiovasc Med, 2018)

Phospholipid remodeling in physiology and disease - Wang, B.; Tontonoz, P. (Annu Rev Physiol, 2019)

Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer - Lebok, P.; Hassel, A.; Meiners, J.; Hube-Magg, C.; Simon, R.; Höflmayer, D. (Aging, 2019)

Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma - Du, Y.; Wang, Q.; Zhang, X.; Wang, X.; Qin, C.; Sheng, Z. (J Exp Clin Cancer Res CR, 2017)

Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer - Mansilla, F.; Costa, K. A.; Wang, S.; Kruhøffer, M.; Lewin, T. M.; Orntoft, T. F. (J Mol Med (Berl), 2009)

LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway - Wei, C.; Dong, X.; Lu, H.; Tong, F.; Chen, L.; Zhang, R. (J Exp Clin Cancer Res CR, 2019)

Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor - Shida-Sakazume, T.; Endo-Sakamoto, Y.; Unozawa, M.; Fukumoto, C.; Shimada, K.; Kasamatsu, A. (PLoS ONE, 2015)

LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production - Han, C.; Yu, G.; Mao, Y.; Song, S.; Li, L.; Zhou, L. (PLoS ONE, 2020)

Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression - Morita, Y.; Sakaguchi, T.; Ikegami, K.; Goto-Inoue, N.; Hayasaka, T.; Hang, V. T. (J Hepatol, 2013)

Oncogene amplification in growth factor signaling pathways renders cancers dependent on membrane lipid remodeling - Bi, J.; Ichu, T. A.; Zanca, C.; Yang, H.; Zhang, W.; Gu, Y. (Cell Metab, 2019)

Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism - Han, Y.; Zhuang, Q.; Sun, B.; Lv, W.; Wang, S.; Xiao, Q. (Nat Commun, 2021)

Bidar M, Bahlakeh A, Mahmoudi M, Ahrari F, Shahmohammadi R, Jafarzadeh H. Does the application of GaAlAs laser and platelet-rich plasma induce cell proliferation and increase alkaline phosphatase activity in human dental pulp stem cells? Lasers in medical science. 2021.

Evaluation of miR-302b-5p expression and molecular mechanism in hepatocellular carcinoma: findings based on RT-qPCR and in silico analysis - Wu, H. Y.; Cai, K. T.; Ma, J.; Chen, G.; Dang, Y. W.; Lu, H. P. (Pathol Res Pract, 2019)

Effect of CELSR3 on the cell cycle and apoptosis of hepatocellular carcinoma cells - Xie, Z.; Dang, Y.; Wu, H.; He, R.; Ma, J.; Peng, Z. (J Cancer, 2020)

MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip - Gao, L.; Yan, S. B.; Yang, J.; Kong, J. L.; Shi, K.; Ma, F. C. (BMC Med Genomics, 2020)

MIR22HG as a tumor suppressive lncRNA in HCC: a comprehensive analysis integrating RT-qPCR, mRNA-Seq, and microarrays - Gao, L.; Xiong, D. D.; He, R. Q.; Yang, X.; Lai, Z. F.; Liu, L. M. (OncoTargets Ther, 2019)

High OGT activity is essential for MYC-driven proliferation of prostate cancer cells - Itkonen, H. M.; Urbanucci, A.; Martin, S. E.; Khan, A.; Mathelier, A.; Thiede, B. (Theranostics, 2019)

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway - Zhou, C.; Liu, C.; Liu, W.; Chen, W.; Yin, Y.; Li, C. W. (Theranostics, 2020)

Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance - Nambiar, D. K.; Aguilera, T.; Cao, H.; Kwok, S.; Kong, C.; Bloomstein, J. (J Clin Invest, 2019)

Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis - Shan, D.; Zou, L.; Liu, X.; Shen, Y.; Cai, Y.; Zhang, J. (Am J Obstet Gynecol, 2020)

The clinical significance of endothelin receptor type B in hepatocellular carcinoma and its potential molecular mechanism - Zhang, L.; Luo, B.; Dang, Y. W.; He, R. Q.; Chen, G.; Peng, Z. G. (Exp Mol Pathol, 2019)

Immune-related prognosis biomarkers associated with osteosarcoma microenvironment - Hong, W.; Yuan, H.; Gu, Y.; Liu, M.; Ji, Y.; Huang, Z. (Cancer Cell Int, 2020)

Significance of tumor mutation burden combined with immune infiltrates in the progression and prognosis of ovarian cancer - Bi, F.; Chen, Y.; Yang, Q. (Cancer Cell Int, 2020)

Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer - Kwon, O. S.; Lee, H.; Kong, H. J.; Kwon, E. J.; Park, J. E.; Lee, W. (Oncogene, 2020)

Zhang C, Chen T, Li Z, Liu A, Xu Y, Gao Y, et al. Depiction of tumor stemlike features and underlying relationships with hazard immune infiltrations based on large prostate cancer cohorts. Briefings in bioinformatics. 2020.

Multiple-purpose connectivity map analysis reveals the benefits of esculetin to hyperuricemia and renal fibrosis - Wang, Y.; Kong, W.; Wang, L.; Zhang, T.; Huang, B.; Meng, J. (Int J Mol Sci, 2020)

Construction of lncRNA-associated ceRNA networks to identify prognostic lncRNA biomarkers for glioblastoma - Liu, Z.; Wang, X.; Yang, G.; Zhong, C.; Zhang, R.; Ye, J. (J Cell Biochem, 2020)

Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway - Ye, G.; Qin, Y.; Wang, S.; Pan, D.; Xu, S.; Wu, C. (Cancer Biol Ther, 2019)

BAY 87-2243 sensitizes hepatocellular carcinoma Hep3B cells to histone deacetylase inhibitors treatment via GSK-3β activation - Li, Y. L.; Rao, M. J.; Zhang, N. Y.; Wu, L. W.; Lin, N. M.; Zhang, C. (Exp Ther Med, 2019)

Activation of mTOR signaling pathway in hepatocellular carcinoma - Ferrín, G.; Guerrero, M.; Amado, V.; Rodríguez-Perálvarez, M.; Mata, M. (Int J Mol Sci, 2020)

Evodiamine induces apoptosis and promotes hepatocellular carcinoma cell death induced by vorinostat via downregulating HIF-1α under hypoxia - Li, Y. L.; Zhang, N. Y.; Hu, X.; Chen, J. L.; Rao, M. J.; Wu, L. W. (Biochem Biophys Res Commun, 2018)

A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4-methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects - Miao, J. F.; Peng, Y. F.; Chen, S.; Gao, W. J.; Yang, Q. X.; Zhu, P. (Eur J Pharmacol, 2018)

Characterization of lipid and lipid droplet metabolism in human HCC - Berndt, N.; Eckstein, J.; Heucke, N.; Gajowski, R.; Stockmann, M.; Meierhofer, D. (Cells, 2019)

Lipid metabolism in development and progression of hepatocellular carcinoma - Sangineto, M.; Villani, R.; Cavallone, F.; Romano, A.; Loizzi, D.; Serviddio, G. (Cancers (Basel)., 2020)

ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy - Tian, Y.; Yang, B.; Qiu, W.; Hao, Y.; Zhang, Z.; Yang, B. (Nat Commun, 2019)

CRISPR/Cas9 for cancer research and therapy - Zhan, T.; Rindtorff, N.; Betge, J.; Ebert, M. P.; Boutros, M. (Semin Cancer Biol, 2019)

A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers - Liu, F.; Wu, Y.; Liu, J.; Ni, R. J.; Yang, A. G.; Bian, K. (Biochem Biophys Res Commun, 2020)

MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7 - Zhao, Y.; Zhu, C.; Chang, Q.; Peng, P.; Yang, J.; Liu, C. (PLoS ONE, 2020)

CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis - Zhu, M.; Xu, W.; Wei, C.; Huang, J.; Xu, J.; Zhang, Y. (Cell Death Dis, 2019)

TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B - Ying, H.; Ji, L.; Xu, Z.; Fan, X.; Tong, Y.; Liu, H. (Cancer Lett, 2020)

PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression - Tian, L.; Yao, K.; Liu, K.; Han, B.; Dong, H.; Zhao, W. (Oncogene, 2020)

Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance - Xie, B.; Wang, S.; Jiang, N.; Li, J. J. (Cancer Lett, 2019)

Limits and constraints on mechanisms of cell-cycle regulation imposed by cell size-homeostasis measurements - Willis, L.; Jönsson, H.; Huang, K. C. (Cell Rep, 2020)

UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation - Sun, J.; Zhu, Z.; Li, W.; Shen, M.; Cao, C.; Sun, Q. (J Exp Clin Cancer Res CR, 2020)

A high-throughput targeted metabolomics method for the quantification of 104 non-polar metabolites in cholesterol, eicosanoid, and phospholipid metabolism: application in the study of a CCl(4)-induced liver injury mouse model - Jia, M.; Peng, Z.; Yang, K.; Su, C.; Wang, Y.; Yan, C. (Analyst, 2020)

Allicin and digestive system cancers: from chemical structure to its therapeutic opportunities - Sarvizadeh, M.; Hasanpour, O.; Naderi Ghale-Noie, Z.; Mollazadeh, S.; Rezaei, M.; Pourghadamyari, H. (Front Oncol, 2021)

Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133-expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway - Zhang, X.; Shao, J.; Li, X.; Cui, L.; Tan, Z. (Oncol Rep, 2019)

Histone deacetylase inhibitors in hepatocellular carcinoma: a therapeutic perspective - Tsilimigras, D. I.; Ntanasis-Stathopoulos, I.; Moris, D.; Spartalis, E.; Pawlik, T. M. (Surg Oncol, 2018)

Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: a single center experience - Zhou, L.; Pan, L. C.; Zheng, Y. G.; Du, G. S.; Fu, X. Q.; Zhu, Z. D. (Oncol Lett, 2018)